China’s National Medical Products Administration’s (NMPA) Center for Drug Evaluation (CDE) has granted breakthrough therapy designation (BTD) for GSK's Blenrep (belantamab mafodotin ...

(RTTNews) - Drug maker GSK plc (GSK, GSK.L) announced Tuesday that Blenrep (belantamab mafodotin) combinations in relapsed/refractory multiple myeloma have been accepted for regulatory review in ...

(Alliance News) - GSK PLC on Tuesday said its Blenrep cancer treatment will undergo review in Japan after successful authorisations recently in the UK and Europe. The London-based pharmaceutical ...

GSK plc announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has accepted for review a new drug application (NDA) for Blenrep (belantamab mafodotin) in combination with bortezomib plus ...

SpaceX will also launch a batch of Starlink satellites from California as the constellation increases to 6,000 operational satellites. Following last weekend’s return and recovery of the Polaris ...

Get ready for a (potential) evening launch from the Space Coast. SpaceX plans to launch the next two Galileo satellites into orbit for the European Space Agency (ESA). The space company is ...

WELLINGTON, Sept 19 (Reuters) - Rocket Lab (RKLB.O), opens new tab said on Thursday that the scheduled launch of its Electron rocket into space from a facility in New Zealand was aborted just ...

A (potential) evening rocket launch is scheduled, and it may be visible from parts of the Treasure Coast. SpaceX plans to launch the next two Galileo satellites into orbit for the European Space ...

GSK continues to build the case for its multiple myeloma therapy Blenrep, which was pulled from the US market last year, with another positive phase 3 trial. The BCMA-targeted antibody-drug ...

View more The billionaire previously claimed that the US regulator was stifling space exploration after refusing to grant a launch licence for its latest Starship craft, which he claims has been ...